All Stories

  1. Considerations of heterogeneity in clinical trials for hepatocellular carcinoma

    Article • Expert Review of Gastroenterology & Hepatology, May 2019, Taylor & Francis

    Chih-Hung Hsu

  2. Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives

    Article • Journal of Hepatocellular Carcinoma, May 2019, Dove Medical Press

    Chun-Jung Chang , Chih-Hung Hsu

  3. Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

    Article • Liver Cancer, January 2019, Karger Publishers

    Chih-Hung Hsu

  4. Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives

    Article • Journal of Hepatocellular Carcinoma, June 2014, Taylor & Francis

    Chih-Hung Hsu, Chiun Hsu